193 related articles for article (PubMed ID: 27641789)
41. Reply to Hein V. Stroomberg, Klaus Brasso, and Andreas Røder's Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.
Uleri A; Baboudjian M; Diamand R; Ploussard G
Eur Urol; 2024 May; ():. PubMed ID: 38796382
[No Abstract] [Full Text] [Related]
42. Reply to Per-Uno Malmström and Bruce J. Trock's Letter to the Editor re: Richard J. Sylvester, Willem Oosterlinck, Sten Holmang, et al. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.050.
Sylvester R
Eur Urol; 2016 Jan; 69(1):e12-3. PubMed ID: 26215601
[No Abstract] [Full Text] [Related]
43. Re: Francesco Porpiglia, Enrico Checcucci, Daniele Amparore, et al. Three-dimensional Augmented Reality Robot-assisted Partial Nephrectomy in Case of Complex Tumours (PADUA ≥ 10): A New Intraoperative Tool Overcoming the Ultrasound Guidance. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.11.024.
Zhang M; Wang L
Eur Urol; 2020 Jun; 77(6):e161-e162. PubMed ID: 32303382
[No Abstract] [Full Text] [Related]
44. Reply to Rui-Cheng Wu, Deng-Xiong Li, and De-Chao Feng's Letter to the Editor re: Michael Eppler, Conner Ganjavi, Lorenzo Storino Ramacciotti, et al. Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology. Eur Urol. 2024;85:146-53.
Eppler M; Ganjavi C; Abreu A; Gill I; Cacciamani GE
Eur Urol; 2024 Mar; 85(3):e85-e86. PubMed ID: 38182492
[No Abstract] [Full Text] [Related]
45. Reply to Nikolaos Grivas, Nikolaos Kalampokis, Markos Karavitakis, Ioannis Leotsakos, Ioannis Katafigiotis, and Henk van der Poel's Letter to the Editor re: Bara Barakat, Hazem Othman, Ulrich Gauger, Ingmar Wolff, Boris Hadaschik, Christian Rehme. Retzius Sparing Radical Prostatectomy Versus Robot-assisted Radical Prostatectomy: Which Technique Is More Beneficial for Prostate Cancer Patients (MASTER Study)? A Systematic Review and Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.08.003.
Barakat B; Rehme C; Hadaschik B
Eur Urol Focus; 2022 Sep; 8(5):1556. PubMed ID: 34933832
[No Abstract] [Full Text] [Related]
46. Re: Roxana Ramos, Ethan Ferguson, Mahmoud Abou Zeinab, et al. Single-port Transvesical Robot-assisted Simple Prostatectomy: Surgical Technique and Clinical Outcomes. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.11.012.
Singh J
Eur Urol; 2024 May; ():. PubMed ID: 38796381
[No Abstract] [Full Text] [Related]
47. Re: Dries Develtere, Giuseppe Rosiello, Pietro Piazza, et al. Early Catheter Removal on Postoperative Day 2 After Robot-assisted Radical Prostatectomy: Updated Real-life Experience with the Aalst Technique. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.10.003.
Montorsi F; Gandaglia G; Dehò F; Mazzone E; Stabile A; Briganti A
Eur Urol Focus; 2022 Nov; 8(6):1861. PubMed ID: 35153172
[No Abstract] [Full Text] [Related]
48. Re: Baojun Wang, Qingbo Huang, Kan Liu, et al. Robot-assisted Level III-IV Inferior Vena Cava Thrombectomy: Initial Series with Step-by-step Procedures and 1-yr Outcomes. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.04.019: Robotic-assisted Laparoscopic Radical Nephrectomy and Tumor Thrombectomy: Is It Exclusively the Approach that Matters?
González J; Ciancio G
Eur Urol; 2020 Mar; 77(3):e72-e73. PubMed ID: 31543364
[No Abstract] [Full Text] [Related]
49. Re: Evanguelos Xylinas, Michael Rink, Eugene K. Cha, et al. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.052.
Luo HL; Chiang PH
Eur Urol; 2012 Nov; 62(5):e92-3. PubMed ID: 22906766
[No Abstract] [Full Text] [Related]
50. Reply to Nikolaos Grivas and Henk G. van der Poel's Letter to the Editor re: Rui Farinha, Giuseppe Rosiello, Artur De Oliveira Paludo, et al. Selective Suturing or Sutureless Technique in Robot-assisted Partial Nephrectomy: Results from a Propensity-score Matched Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.019.
Farinha R; Rosiello G; Puliatti S; Mottrie A
Eur Urol Focus; 2022 May; 8(3):888-889. PubMed ID: 34031018
[No Abstract] [Full Text] [Related]
51. Re: Sanoj Punnen, Matthew R. Cooperberg, Anthony V. D'Amico, et al. Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.05.025: Re: Firas Abdollah, Nazareno Suardi, Cesare Cozzarini, et al. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. Eur Urol 2013;63:998-1008.
Parker C; Sydes MR; Kynaston H;
Eur Urol; 2013 Nov; 64(5):e102. PubMed ID: 23953599
[No Abstract] [Full Text] [Related]
52. Re: Vinayak G. Wagaskar, Ankur Mittal, Stanislaw Sobotka, et al. Hood Technique for Robotic Radical Prostatectomy-Preserving Periurethral Anatomical Structures in the Space of Retzius and Sparing the Pouch of Douglas, Enabling Early Return of Continence Without Compromising Surgical Margin Rates. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.044.
Grivas N; Dell'Oglio P; De Groote R; Turri F; Mamoulakis C; Larcher A;
Eur Urol; 2021 May; 79(5):e152-e153. PubMed ID: 33648790
[No Abstract] [Full Text] [Related]
53. Reply to Chris R. Cardwell, Samy Suissa and Liam J. Murray's letter to the editor re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA
Eur Urol; 2013 Jul; 64(1):e11-2. PubMed ID: 23602404
[No Abstract] [Full Text] [Related]
54. Reply to Stephen B. Williams, Donald L. Lamm, Ashish M. Kamat's Letter to the Editor re: Richard J. Sylvester, Willem Oosterlinck, Sten Holmang, et al. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.050.
Sylvester R
Eur Urol; 2015 Dec; 68(6):e128. PubMed ID: 26320375
[No Abstract] [Full Text] [Related]
55. Re: Pär Stattin, Fredrik Sandin, Frederik Birkebæk Thomsen, et al. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.023: Radical Treatment in Very High-risk Prostate Cancer: Venturing Down a Path Less Travelled.
Santok GD; Rha KH
Eur Urol; 2017 Apr; 71(4):e113-e114. PubMed ID: 27717521
[No Abstract] [Full Text] [Related]
56. Re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.010.
Lombardo R; Riolo S; De Nunzio C
Eur Urol Oncol; 2023 Oct; ():. PubMed ID: 37872030
[No Abstract] [Full Text] [Related]
57. Re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.010.
Montorsi F; Rosiello G; Gandaglia G; Salonia A; Briganti A
Eur Urol Oncol; 2024 Jun; 7(3):636. PubMed ID: 37951819
[No Abstract] [Full Text] [Related]
58. Reply to Stefano C.M. Picozzi, Cristian Ricci and Luca Carmignani's letter to the editor re: Giacomo Novara, Vincenzo Ficarra, Simone Mocellin, et al. Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol 2012;62:382-404.
Novara G; Ficarra V
Eur Urol; 2013 Feb; 63(2):e29-31. PubMed ID: 23218764
[No Abstract] [Full Text] [Related]
59. Reply to Erfan Ayubi and Saeid Safiri's Letter to the Editor re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036. Methodological Issues.
Trock BJ; Karnes RJ
Eur Urol; 2017 Dec; 72(6):e158-e159. PubMed ID: 28576503
[No Abstract] [Full Text] [Related]
60. Reply to Giancarlo Marra, Armando Stabile, Paolo Gontero, Francesco Montorsi, Alberto Briganti, and Giorgio Gandaglia's Letter to the Editor re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019: A Storm in a Teacup.
Meissner VH; Gschwend JE; Heck MM
Eur Urol; 2022 May; 81(5):e117. PubMed ID: 35131117
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
